Aggreguide A-100 ADP Assay Evaluation

AggreDyne

Status: Completed

Conditions: ADP Blockers; Platelet Aggregation

Treatments: Other: platelet aggregation measurement

Study type: Observational

Funder types: Industry

Identifiers

NCT02112539

Val 0072-B

Details and patient eligibility

About

The study is to characterize the AggreGuide ADP Assay's performance.

Enrollment: 150 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 18-75

Exclusion criteria

• less than 60 kg
• on antiplatelet meds other than aspirin
• antiplatelet drugs contraindicated

Trial design

150 participants in 1 patient group

ADP Blockers

Description:

platelet aggregation in response to antiplatelet drugs

Treatment:

Other: platelet aggregation measurement